Although 5-Aza is shown in vitro and in vivo to inhibit DNMT1 and enhance therapeutic response in many cancers, caution should be exercised as genome-wide inhibition of DNA methylation might activate certain oncogenes. Here, DNMT1 is linked to cancer.